• California is 1st state to require pharmacists to report errors

    California is the first state to require pharmacists to report every prescription mistake.
  • Transform Your Hospital Operations: A Virtual Summit

    Sponsored
    Nearly 190 health systems are reimagining hospital operations with AI. Learn how, here.
  • Walgreens walkout enters last day: 5 notes

    After seeing success from CVS pharmacy workers calling out of work over staffing concerns in Kansas City, Walgreens employees organized a walkout — but it's unclear whether the scattered labor action will result in change.
  • Employer coverage of weight-loss drugs set to double in 2024

    Forty-three percent of employers plan to cover weight loss drugs in 2024, nearly double the proportion of employers that cover them now, according to newly released survey findings from Accolade. 
  • Mark Cuban's pharmacy racks up collaborators

    Nearly two years after Mark Cuban launched a mail-order pharmacy with low-cost medications, the entrepreneur and "Shark Tank" star has secured more than a dozen collaborators. 
  • DEA, HHS issue 2nd extension of controlled substances via telehealth

    The U.S. Drug Enforcement Agency is, for a second time, extending clinicians' ability to prescribe controlled substances using telehealth services, according to a revised rule the agency published. 
  • 5 drugs now in shortage

    Since mid-September, drugmakers have reported five new drug shortages, including medications for lung cancer, hypertension and eye infections. 
  • Walgreens pharmacists plan walkout

    An unclear number of Walgreens pharmacies might close Oct. 9-11 after pharmacists shared plans through social media apps, emails and fliers to stage a walkout, according to CNN. 
  • Minnesota system buys independent pharmacy

    Staples, Minn.-based Lakewood Health System is acquiring a local pharmacy. 
  • Cancer drug study partially halted after patient death

    After a study participant died from a severe and rare inflammatory syndrome, the FDA placed a partial clinical hold on a France-based drugmaker's cancer drug trial. 
  • Mark Cuban's drug company, caregiver app team up

    Mark Cuban Cost Plus Drug Co. recently penned a deal with Avanlee Care, which runs an app designed to help caregivers for elderly patients. 
  • Walmart: Ozempic leading to fewer food purchases

    Walmart is experiencing less food demand from individuals taking GLP-1s such as Ozempic or Wegovy, Bloomberg reported Oct. 4.
  • Cancer drug shortage slightly eases

    The national shortage of multiple cancer therapies is marginally improving compared to early summer, according to an Oct. 5 update from the National Comprehensive Cancer Network. 
  • Kaiser closes some outpatient pharmacies amid strike

    As about 75,000 Kaiser Permanente workers strike in six states, the Oakland, Calif.-based system has temporarily closed at least 18 outpatient pharmacies across four states.
  • FDA probes phony Ozempic schemes

    The FDA has started investigating schemes to sell counterfeit versions of Ozempic to unsuspecting pharmacies, according to an Oct. 4 industry alert obtained by CBS News. 
  • Study links Ozempic with stomach paralysis

    The active ingredients of Ozempic, Wegovy and Saxenda are associated with stomach paralysis, according to a study published Oct. 5 in JAMA. 
  • AbbVie's oral cancer drug trial shows it may provide 'anti-tumor immunity'

    Research for a new oral cancer medication from pharmaceutical giant AbbVie yielded positive preclinical data that shows it "enhances anti-tumor immunity," according to an Oct. 4 news release. 
  • Moderna to move forward with combo flu, COVID-19 shot

    Moderna is moving forward with plans to develop a combination vaccine for flu and COVID-19 after early-stage studies yielded positive results, the company said Oct. 3. 
  • 31 drugmakers, biotechs form pro-M&A group

    More than two dozen life science, pharmaceutical and biotech organizations partnered Oct. 4 to build a coalition advocating for mergers and acquisitions in the life sciences industry. 
  • Paxlovid reduces COVID-19 mortality only among highest risk patients: Study

    Paxlovid (nirmatrelvir-ritonavir), a COVID-19 antiviral treatment, was found to be effective in reducing hospitalizations and deaths only among "the most clinically extremely vulnerable individuals," according to a study published Oct. 2 in JAMA. 
  • Mark Cuban takes aim at pink tax

    As Mark Cuban Cost Plus Drug Co. continues to make waves in the pharmaceutical market, it will soon begin to offer Clomid, a common fertility drug, to its customers.

Featured Whitepapers

Featured Webinars